Frailty
Conditions
Keywords
frailty, intervention, multidomain, digital
Brief summary
The goal of this feasibility randomized controlled trial is to investigate the applicability of software that aims to improve symptoms of frailty by implementing customized interventions such as physical exercise and cognitive training implemented through a mobile app for 16 weeks for patients diagnosed with frailty or prefrailty. The primary outcomes are adherence, retention rates, and recruitment rates. Participants will participate in customized interventions including physical exercise, cognitive training, nutritional guidance, and management of disease related to frailty for 16 weeks.
Detailed description
The physical exercise program will comprise aerobic exercise, balance-improving exercises, flexibility-enhancing activities, and strength-building exercises targeting major muscle groups through a mobile app . Customized cognitive training, performed using a mobile app, targets the cognitive domains of prospective memory and executive function. Nutritional intervention will be performed to treat frailty symptoms and disease related to frailty through a mobile app. Education and management of disease related to frailty will be done through a mobile app.
Interventions
BEHAVIORALLifestyle Management
For 16 weeks, participants will receive exercise, cognitive training, nutrition education, and disease education through a smartphone app, and the content and intensity of the intervention will be adjusted every four weeks through an assessment of frailty symptoms through the app.
Sponsors
Seong Hye Choi, MD
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
60 Years to 90 Years
Healthy volunteers
No
Inclusion criteria
* 60-90 years of age * Residing in the community * Total score of Modified Fried frailty phenotype score ≥ 1 point * Korean Mini-Mental State Examination-2 z-score ≥ -1.5 * Can read and write * Being able to use the a mobile app through education or having someone help a participant use the mobile app * Having a reliable informant who could provide investigators with the requested information. * written informed consent
Exclusion criteria
* Major psychiatric illness such as major depressive disorders * Dementia * Other neurodegenerative disease (e.g., Parkinson's disease) * Malignancy within five years * Cardiac stent or revascularization within one year * Serious or unstable symptomatic cardiovascular disease * Other serious or unstable medical disease such as acute or severe asthma, active gastric ulcer, severe liver disease, or severe renal disease * Severe loss of vision, hearing, or communicative disability * Significant laboratory abnormality that may result in cognitive impairment * Any conditions preventing cooperation as judged by the study physician * Unable to participate in exercise program safely * Coincident participation in any other intervention trial
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| retention rate | From enrollment to the end of intervention at 16 weeks | retention rate ≥ 70% |
| Adherence to the protocol | From enrollment to the end of intervention at 16 weeks | Adherence to the protocol ≥ 70% |
| recruitment rate | From enrollment to the end of intervention at 16 weeks | recruitment rate ≥ 50%. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change from Baseline in 14-item cognitive subscale of the Alzheimer's Disease Assessment Scale at 16 weeks | From baseline to the end of intervention at 16 weeks | The score ranges from 0 to 90. A lower score indicates better performance. |
| Change from Baseline in Korean Mini-Mental State Examination-2 at 16 weeks | From enrollment to the end of intervention at 16 weeks | The score ranges from 0 to 30. A higher score indicates better performance. |
| Change from Baseline in Clinical Dementia Rating scale-Sum of Boxes at 16 weeks | From baseline to the end of intervention at 16 weeks | The score ranges from 0 to 18. A lower score indicates better performance. |
| Change from Baseline in Korean Instrumental Activities of Daily Living at 16 weeks | From baseline to the end of intervention at 16 weeks | The score ranges from 0 to 3. A lower score indicates better performance. |
| Change from Baseline in Modified Barthel Index: at 16 weeks | From baseline to the end of intervention at 16 weeks | The score ranges from 0 to 100. A higher score indicates better performance. |
| Change from Baseline in Center for Epidemiological Studies-Depression Scale at 16 weeks | From baseline to the end of intervention at 16 weeks | The score ranges from 0 to 60. A lower score indicates better performance. |
| Change from Baseline in Quality of life-Alzheimer's disease at 16 weeks | From baseline to the end of intervention at 16 weeks | The score ranges from 0 to 52. A higher score indicates better performance. |
| Change from Baseline in gait speed at 16 weeks | From baseline to the end of intervention at 16 weeks | A lower score indicates better performance. |
| Change from Baseline in Short Physical Performance Battery at 16 weeks | From baseline to the end of intervention at 16 weeks | The score ranges from 0 to 12. A higher score indicates better performance. |
| Change from Baseline inTimed Up and Go test at 16 weeks | From baseline to the end of intervention at 16 weeks | A lower score indicates better performance. |
| Change from Baseline in 30 s sit-to-stand at 16 weeks | From baseline to the end of intervention at 16 weeks | A higher score indicates better performance. |
| Change from Baseline in 2 min stepping test at 16 weeks | From baseline to the end of intervention at 16 weeks | A higher score indicates better performance. |
| Change from Baseline in Mini Nutritional Assessment at 16 weeks | From baseline to the end of intervention at 16 weeks | The score ranges from 0 to 14. A higher score indicates better performance. |
| Change from Baseline in Korean Frailty Index for Primary Care at 16 weeks | From baseline to the end of intervention at 16 weeks | The score ranges from 0 to 1. A lower score indicates better performance. |
| Change from Baseline in skeletal muscle mass at 16 weeks | From baseline to the end of intervention at 16 weeks | A higher score indicates better performance. |
| Number of Participants with Treatment-Related Adverse Events | From enrollment to the end of intervention at 16 weeks | A lower score indicates better performance. |
| Change from baseline in MIND diet checklist at 16 weeks | From baseline to the end of intervention at 16 weeks | The score ranges from 0 to 15. A higher score indicates better performance. |
| Change from baseline in International Physical Activity Questionnaire-Short Form at 16 weeks | From baseline to the end of intervention at 16 weeks | The score ranges from 0 to 20,000. A higher score indicates better performance. |
| Change from baseline in LDL-C at 16 weeks | From baseline to the end of intervention at 16 weeks | The score ranges from 0 to 300. A lower score indicates better performance. |
| Change from baseline in HDL-C at 16 weeks | From baseline to the end of intervention at 16 weeks | The score ranges from 0 to 200. A higher score indicates better performance. |
| Change from baseline in HbA1c at 16 weeks | From baseline to the end of intervention at 16 weeks | The score ranges from 0 to 30. A lower score indicates better performance. |
| Change from baseline in eGFR at 16 weeks | From baseline to the end of intervention at 16 weeks | The score ranges from 0 to 200. A higher score indicates better performance. |
| Change from baseline in blood pressure at 16 weeks | From baseline to the end of intervention at 16 weeks | The score ranges from 0 to 250. A lower score indicates better performance. |
| Change from baseline in body weight at 16 weeks | From baseline to the end of intervention at 16 weeks | The score ranges from 0 to 200. A higher score indicates better performance in frailty. |
| Change from baseline in waist circumference at 16 weeks | From baseline to the end of intervention at 16 weeks | The score ranges from 0 to 200. A higher score indicates better performance in frailty. |
| Occurrence of aging-related diseases | From baseline to the end of intervention at 16 weeks | The score ranges from 0 to 10. A lower score indicates better performance. |
| Change from Baseline in Nutritional Quotient for Elderly at 16 weeks | From baseline to the end of intervention at 16 weeks | The score ranges from 0 to 100. A higher score indicates better performance. |
| Change from Baseline in Modified Fried frailty phenotype score at 16 weeks | From baseline to the end of intervention at 16 weeks | The score ranges from 0 to 5. A lower score indicates better performance. |
| Change from Baseline in Lubben Social Network Scale at 16 weeks | From baseline to the end of intervention at 16 weeks | The score ranges from 0 to 50. A higher score indicates better performance. |
Countries
South Korea
Contacts
Primary ContactSeong Hye Choi, MD, PhD
Outcome results
None listed